- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT03572504
Height Measurement in Critically Ill Children
Comparison to World Health Organization (WHO) Gold Standard of Extrapolation and Estimation Methods to Assess Length/Height in Critically Ill Children
Height/length has to be assessed accurately in critically ill children, as its value is required to assess nutritional status, to calculate nutritional requirements, to calculate body surface area (involved in drug prescriptions), and to assess pulmonary function.
The WHO has standardized practices to perform height/length measurements, but this gold standard is not applicable in critically ill children (who cannot stand and are equipped with catheters, tubes and various devices). It is not accurate to rely on previous measurements as children are continuously growing. No height/length measurement tool or method has been validated so far in this population, neither any estimation nor extrapolation methods.
The investigators aim to compare the WHO gold standard for height/length measurement to a list of other methods, validated in other children populations and currently used in the pediatric setting. We intend to compare each of them to the gold standard. The secondary objectives are to describe each height/length extrapolation or estimation method and to estimate the practical use of each method for critically ill children.
A prospective observational study is planned. 140 critically ill children admitted to pediatric intensive care unit (PICU) will be recruited.
Body segments (ulna, tibia, knee-heel, arm span) will be measured and length/height extrapolated from formulas used in different populations. Previous length/height measurements will be collected to draw growth curves and extrapolate actual length/height. Parents will be asked how tall their child is.
After PICU discharge, while the child meets WHO measurement standards, accurate length/height will be measured and compared to the results of the above mentioned techniques.
Comparison will be made in-between these results.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Undersøgelsestype
Tilmelding (Faktiske)
Kontakter og lokationer
Studiesteder
-
-
-
Strasbourg, Frankrig, 67098
- Hôpitaux Universitaires de Starsbourg
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Prøveudtagningsmetode
Studiebefolkning
Beskrivelse
Inclusion Criteria:
- age from 28 days to 18 years
- admitted in pediatric intensive care
- WHO standard not applicable
- parent consent
Exclusion criteria:
- expected death before discharge
- expected that the child will not meet in the near future WHO standard criteria to measure height/length
- growth > 5% height before meeting the WHO criteria
- limb abnormalities, scoliosis, retractions.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Observationsmodeller: Kohorte
- Tidsperspektiver: Fremadrettet
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
---|---|---|
identify the most reliable method (s) of pediatric resuscitation.
Tidsramme: 110 days
|
Compare a series of measurement or size estimation techniques to the WHO standard to identify the most reliable method (s) of pediatric resuscitation.
|
110 days
|
Samarbejdspartnere og efterforskere
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
- 6910 (Anden identifikator: CTEP)
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .
Kliniske forsøg med Ernæringsstatus
-
Arizona State UniversityCatholic Charities Phoenix; Phoenix International Refugee Committee; Refugee... og andre samarbejdspartnereAfsluttetKvindelig kønslemlæstelse Type I Status | Kvindelig kønslemlæstelse Type II Status | Kvindelig kønslemlæstelse Type III StatusForenede Stater
-
Piazza della Vittoria 14 Studio Medico - Ginecologia...AfsluttetKvindelig kønslemlæstelse Type I Status | Kvindelig kønslemlæstelse Type II Status | Kvindelig kønslemlæstelse Type III StatusItalien
-
Sohag UniversityAfsluttetStatus Epilepticus | Generaliseret konvulsiv status epilepticus | Status Epilepticus, generaliseret | Status Epilepticus, Generaliseret KonvulsivEgypten
-
FlevoziekenhuisRekruttering
-
Newcastle UniversityFera Science Ltd.AfsluttetSelen statusDet Forenede Kongerige
-
University of SouthamptonAktiv, ikke rekrutterendeRedox statusDet Forenede Kongerige
-
Società Italiana Talassemie ed EmoglobinopatieUniversity of Campania "Luigi Vanvitelli"AfsluttetSplenektomi; Status
-
Institut de Recherche pour le DeveloppementPATH; Department of Fisheries Post-harvest Technologies and Quality Control og andre samarbejdspartnereAfsluttet
-
Johns Hopkins Bloomberg School of Public HealthBill and Melinda Gates Foundation; International Center for Diarrheal Disease...Rekruttering
-
Atos Medical ABPeking Union Medical College Hospital; Beijing Tongren Hospital; Eye & ENT...Aktiv, ikke rekrutterende